IMUX Appoints Erik Lundgren as CEO, Advances Vidofludimus Calcium Through Late-Stage MS Trials
Immunic, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.13
+12% in 1d after detection
Post-detection moves
1h
-2.1%
1d
+12%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS